PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | +33.3% | 6,500 | +47.7% | 0.00% | – |
| Q1 2017 | $3,000 | +200.0% | 4,400 | -23.9% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 5,779 | +25.6% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 4,600 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -50.0% | 4,600 | -47.2% | 0.00% | – |
| Q1 2016 | $4,000 | -60.0% | 8,715 | -0.5% | 0.00% | – |
| Q4 2015 | $10,000 | -92.7% | 8,763 | -93.5% | 0.00% | – |
| Q3 2015 | $137,000 | -72.4% | 134,500 | -64.6% | 0.00% | – |
| Q2 2015 | $497,000 | -0.2% | 380,017 | +3.0% | 0.00% | – |
| Q1 2015 | $498,000 | +8200.0% | 368,849 | +8188.7% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 4,450 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -25.0% | 4,450 | 0.0% | 0.00% | – |
| Q2 2014 | $8,000 | 0.0% | 4,450 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | +33.3% | 4,450 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 4,450 | -6.1% | 0.00% | – |
| Q3 2013 | $6,000 | +20.0% | 4,741 | +6.5% | 0.00% | – |
| Q2 2013 | $5,000 | – | 4,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 148,006 | $206,000 | 0.10% |
| First Heartland Consultants, Inc. | 86,204 | $120,000 | 0.07% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $934,000 | 0.02% |
| Investors Capital Advisory Services | 47,238 | $65,000 | 0.02% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $28,000 | 0.01% |
| Commonwealth Equity Services, Inc | 481,140 | $669,000 | 0.01% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $16,000 | 0.01% |
| First Allied Advisory Services, Inc. | 50,000 | $70,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 13,200 | $18,000 | 0.01% |
| AMALGAMATED BANK | 16,650 | $23,000 | 0.00% |